91Ö±²¥

All publications

Journal articles

• Saidi Y, Brennan A & Weich S (2024) . The Lancet, 404, S13-S13.
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2024) . European Journal of Public Health, 34(Supplement_3).
• Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) . BMC Public Health, 24(1).
• Morris D, Angus C, Gillespie D, Stevely A, Pryce R, Wilson L, Henney M, Meier P, Holmes J & Brennan A (2024) . The Lancet Public Health.
• Flight L, Brennan A, Wilson I & Chick SE (2024) . Value in Health.
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2024) . Value in Health.
• Buckell J, Mitchell CA, Fryer K, Newbert C, Brennan A, Joyce J, Jebb SA, Aveyard P, Guess N & Morris E (2024) . Diabetes Care, 47(7), 1239-1239.
• Bates S, Breeze P, Thomas C, Jackson C, Church O & Brennan A (2024) . BMC Public Health, 24.
• Höhn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Cunningham A, Elsenbroich C, Hughes C, Katikireddi SV , McCartney G et al (2024) . BMJ Open, 14(3), e076704-e076704.
• Purshouse RC, Buckley C & Brennan A (2024) . Environmental Modelling & Software, 173, 105959-105959.
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) . Value in Health, 26(12), S544-S544.
• Pryce R, Wilson LB, Gillespie D, Angus C, Morris D & Brennan A (2023) . Drug and Alcohol Review.
• Hatchard J, Buykx P, Wilson L, Brennan A & Gillespie D (2023) . International Journal of Drug Policy, 122, 104247-104247.
• Pidd K, Breeze P, Pollard D, Ahern A, Mueller J & Brennan A (2023) . The Lancet, 402, S75-S75.
• Buckley C, Breeze P, Brennan A, Colasanti R, Leach M & Purshouse R (2023) . Appetite, 189, 106933-106933.
• Mueller J, Jones RA, Richards R, Woolston J, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ, Boothby C , Bostock J et al (2023) . Appetite, 189, 106907-106907.
• Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) . Public Health, 220, 43-49.
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) . Health Economics.
• Vu TM, Buckley C, Duro JA, Brennan A, Epstein JM & Purshouse RC (2023) . Journal of Artificial Societies and Social Simulation, 26(2).
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2022) . Addiction.
• Ahern AL, Breeze P, Fusco F, Sharp SJ, Islam N, Wheeler GM, Hill AJ, Hughes CA, Duschinsky R, Thomas C , Bates S et al (2022) . The Lancet Public Health, 7(10), e866-e875.
• Broadley M, Chatwin H, Søholm U, Amiel SA, Carlton J, De Galan BE, Hendrieckx C, McCrimmon RJ, Skovlund SE, Pouwer F & Speight J (2022) . BMJ Open Diabetes Research and Care, 10(4).
• Thomas C, Breeze P, Cummins S, Cornelsen L, Yau A & Brennan A (2022) . International Journal of Behavioral Nutrition and Physical Activity, 19.
• Divilly P, Zaremba N, Mahmoudi Z, Søholm U, Pollard D, Broadley M, Abbink E, de Galan B, Pedersen-Bjergaard U, Renard E , Evans M et al (2022) . Diabetic Medicine.
• Ahern AL, Richards R, Jones RA, Whittle F, Mueller J, Woolston J, Sharp SJ, Hughes CA, Hill AJ, Duschinsky R , Lawlor ER et al (2022) . BMJ Open, 12(4), e058103.
• Kersbergen I, Buykx P, Brennan A, Brown J, Michie S & Holmes J (2022) . Drug and Alcohol Review.
• Bates SE, Thomas C, Islam N, Ahern AL, Breeze P, Griffin S & Brennan A (2022) . BMC Public Health, 22(1).
• Søholm U, Broadley M, Zaremba N, Divilly P, Nefs G, Mahmoudi Z, de Galan B, Pedersen-Bjergaard U, Brennan A, Pollard DJ , McCrimmon RJ et al (2022) . BMJ Open, 12(2).
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al (2022) . JMIR Form Res, 6(1), e31801.
• Flight L, Julious S, Brennan A & Todd S (2021) . Medical Decision Making.
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies M, Eborall H, Edwardson C, Gray L, Hardeman W, Heathcote L , Henson J et al (2021) . Health Technology Assessment, 25(77).
• Buckley C, Field M, Vu TM, Brennan A, Greenfield TK, Meier PS, Nielsen A, Probst C, Shuper PA & Purshouse RC (2021) . Addictive Behaviors, 107094-107094.
• Matteo Luca Battisti N, Hatton MQ, WR Reed M, Herbert E, Morgan JL, Bradburn M, Simcock R, Walters SJ, Collins KA, Ward SE , Holmes GR et al (2021) . Radiotherapy and Oncology.
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, Edwardson CL, Gray LJ, Hardeman W, Heathcote L , Henson J et al (2021) . BMC Medicine, 19.
• Ring A, Battisti NML, Reed MWR, Herbert E, Morgan JL, Bradburn M, Walters SJ, Collins KA, Ward SE, Holmes GR , Burton M et al (2021) . British Journal of Cancer.
• Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, Manthey J, Purshouse RC, Rovira P, Shuper PA & Shield KD (2021) . Drug and Alcohol Review.
• Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, Martin C, Collins K, Ward S, Holmes G , Burton M et al (2021) . British Journal of Surgery, 108(3), 315-325.
• Patra J, Buckley C, Kerr WC, Brennan A, Purshouse RC & Rehm J (2021) . Drug and Alcohol Review.
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2021) . Public Health Research, 9(4).
• Battisti NML, Reed MWR, Herbert E, Morgan JL, Collins KA, Ward SE, Holmes GR, Bradburn M, Walters SJ, Burton M , Lifford K et al (2021) . European Journal of Cancer, 144, 269-280.
• Holmes GR, Ward SE, Brennan A, Bradburn M, Morgan JL, Reed MWR, Richards P, Rafia R, Wyld L, Burton M , Lifford K et al (2021) . Value in Health.
• Wyld L, Reed MWR, Morgan J, Collins K, Ward S, Holmes GR, Bradburn M, Walters S, Burton M, Herbert E , Lifford K et al (2021) . European Journal of Cancer, 142, 48-62.
• Schneider PP, Smith RA, Bullas AM, Quirk H, Bayley T, Haake SJ, Brennan A & Goyder E (2020) . Public Health, 189, 48-53.
• Holmes J, Beard E, Brown J, Brennan A, Kersbergen I, Meier PS, Michie S, Stevely AK & Buykx P (2020) . Public Health Research, 8(14).
• Si L, Willis MS, Asseburg C, Nilsson A, Tew M, Clarke PM, Lamotte M, Ramos M, Shao H, Shi L , Zhang P et al (2020) . Value in Health.
• Moore S, Allen D, Amos Y, Blake J, Brennan A, Buykx P, Goodacre S, Gray L, Irving A, O'Cathain A , Sivarajasingam V et al (2020) . Health Services and Delivery Research, 8(24).
• Vu TM, Buckley C, Bai H, Nielson A, Probst C, Brennan A, Shuper P, Strong M & Purshouse R (2020) . Complexity, 2020.
• Thokala P, Dodd P, Baalbaki H, Brennan A, Dixon S & Lowrie K (2020) . Value in Health, 23(6), 743-750.
• Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, Heller S & Ismail K (2020) . Health Technology Assessment, 24(28).
• Vu T, Probst C, Nielsen A, Bai H, Buckley C, Meier P, Strong M, Brennan A & Purshouse R (2020) . Journal of Artificial Societies and Social Simulation, 23(3).
• Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) . Value in Health.
• Ahern AL, Woolston J, Wells E, Sharp SJ, Islam N, Lawlor ER, Duschinsky R, Hill AJ, Doble B, Wilson E , Morris S et al (2020) . BMJ Open, 10(4).
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR & Ismail K (2020) . BMJ Open Diabetes Research & Care, 8(1).
• Angus C, Pryce R, Holmes J, de Vocht F, Hickman M, Meier P, Brennan A & Gillespie D (2020) . Addiction.
• Flight L, Julious S, Brennan A, Todd S & Hind D (2020) . Trials, 21(1).
• Churchill S, Angus C, Purshouse R, Brennan A & Sherk A (2020) . Statistical Methods in Medical Research.
• Langley T, Gillespie D, Lewis S, Eminson K, Brennan A, Docherty G & Young B (2020) . Journal of Public Health.
• Probst C, Vu TM, Epstein JM, Nielsen AE, Buckley C, Brennan A, Rehm J & Purshouse RC (2020) . Health Education and Behavior.
• Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, De Angelis D, Carter N , Murray B et al (2020) . Addiction.
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K (2020) . Diabetic Medicine.
• Jiang H, Livingston M, Room R, Callinan S, Marzan M, Brennan A & Doran C (2020) . Addiction.
• Pryce R, Angus C, Holmes J, Gillespie D, Buykx P, Meier P, Hickman M, de Vocht F & Brennan A (2020) . Population Health Metrics, 18(1).
• Kearns B, Stevens J, Ren S & Brennan A (2020) . PharmacoEconomics, 38(2), 193-204.
• Bates S, Bayley T, Norman P, Breeze P & Brennan A (2019) . Medical Decision Making.
• Meier P, Purshouse R, Bain M, Bambra C, Bentall R, Birkin M, Brazier J, Brennan A, Bryan M, Cox J , Fell G et al (2019) . Wellcome Open Research, 4.
• Eminson K, Gillespie D, Lewis S, Opazo-Breton M, Bogdanovica I, Brennan A, Britton J, Wu Q, Meier P, Holmes J & Langley T (2019) . Oral Presentations.
• Marchand R, Genovese A, Koh SCL & Brennan A (2019) . Energy Policy, 130, 206-217.
• Jiang H, Room R, Livingston M, Callinan S, Brennan A, Doran C & Thorn M (2019) . BMJ Open, 9(6).
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2019) . Addiction, 114(4), 607-608.
• Flight L, Arshad F, Barnsley R, Patel K, Julious S, Brennan A & Todd S (2019) . Value in Health.
• Brennan A, Hill-McManus D, Stone T, Buykx P, Ally A, Pryce RE, Alston R, Jones A, Cairns D, Millar T , Donmall M et al (2019) . Journal of Studies on Alcohol and Drugs Supplement(Sup 18), 96-109.
• Di Tanna GL, Porter JK, Lipton RB, Brennan A, Palmer S, Hatswell AJ, Sapra S & Villa G (2019) . BMC Medical Research Methodology, 19.
• Angus C, Li J, Romero-Rodriguez E, Anderson P, Parrott S & Brennan A (2019) . European Journal of Public Health, 29(2), 219-225.
• Bhattacharya A, Angus C, Pryce R, Holmes J, Brennan A & Meier PS (2018) . Addiction, 113(12), 2225-2232.
• Addison M, Mcgovern R, Angus C, Becker F, Brennan A, Brown H, Coulton S, Crowe L, Gilvarry E, Hickman M , Howel D et al (2018) . Alcohol and Alcoholism, 53(5), 548-559.
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2018) . Addiction.
• Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S & Dodick D (2018) . Journal of Medical Economics, 21(7), 666-675.
• de Vocht F, Angus C, Tilling K, Brennan A & Hickman M (2018) . Journal of Epidemiology and Community Health, 72(9), 864-864.
• Breeze P, Womack R, Pryce R, Brennan A & Goyder E (2018) . PLoS ONE, 13(5).
• Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V , Lamotte M et al (2018) . Value in Health.
• Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H & White D (2018) . BMJ Open, 8(4).
• Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K, Bell R, Araújo-Soares V, White M, Summerbell C , Goyder E et al (2018) . BMJ Open, 8(2), e019467-e019467.
• Holmes J, Meier PS, Angus C & Brennan A (2018) . Addiction, 113(2), 203-204.
• Purshouse RC, Brennan A, Holmes J & Meier PS (2018) . Addiction, 113(2), 372-373.
• Grimm SE, Strong M, Brennan A & Wailoo A (2017) . PharmacoEconomics, 35(12), 1287-1296.
• Meier P, Brennan A, Angus C & Holmes J (2017) . BMJ, 359.
• Salleh S, Thokala P, Brennan A, Hughes R & Dixon S (2017) . PharmacoEconomics, 35(10), 989-1006.
• de Vocht F, Tilling K, Pliakas T, Angus C, Egan M, Brennan A, Campbell R & Hickman M (2017) . Journal of Epidemiology and Community Health, 71, 912-918.
• Salleh S, Thokala P, Brennan A, Hughes R & Booth A (2017) . PharmacoEconomics, 35(9), 937-949.
• Thomas C, Sadler S, Breeze P, Squires H, Gillett M & Brennan A (2017) . BMJ Open, 7.
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(8), 1136-1144.
• Gavens L, Holmes J, Buykx P, de Vocht F, Egan M, Grace D, Lock K, Mooney JD & Brennan A (2017) . Health & Place.
• Purshouse RC, Brennan A, Moyo D, Nicholls J & Norman P (2017) . Alcohol and Alcoholism, 52(3), 372-381.
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(5), 632-640.
• Angus CR, Holmes J, Maheswaran R, Green M, Meier P & Brennan A (2017) . International Journal of Environmental Research and Public Health, 4.
• Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A & Meier P (2017) . Addiction, 112(5), 808-817.
• Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A , Campbell M et al (2017) . Health Technology Assessment, 21(20), 1-278.
• Angus CR, Thomas C, Anderson P, Meier P & Brennan A (2017) . European Journal of Public Health, 27(2), 345-351.
• Heller S, Amiel S, Campbell M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R , Waugh N et al (2017) . BMJ, 356.
• Holloway AS, Ferguson J, Landale S, Cariola L, Newbury-Birch D, Flynn A, Knight JR, Sherritt L, Harris SK, O’Donnell AJ , Kaner E et al (2017) . Addiction Science & Clinical Practice, 12(S1).
• Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) . J Public Health (Oxf), 38(4), 679-687.
• Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H & Kruger J (2016) . Medical Decision Making, 36(8), 1020-1033.
• Thomas C, Breeze P, Strong M, Brennan A, Norman P, Cameron D & Epton T (2016) . Journal of Public Health & Epidemiology, 8(10), 191-203.
• Basarir H, Brennan A, Jacques RM, Pollard D, Stevens K, Freeman J, Wales J & Price K (2016) . International Journal of Technology Assessment in Health Care, 32(4), 203-211.
• Beard E, Brown J, West R, Angus C, Brennan A, Holmes J, Kaner E, Meier P & Michie S (2016) . PLoS One, 11(9), e0160666-e0160666.
• De Vocht F, Brown J, Beard E, Angus C, Brennan A, Michie S, Campbell R & Hickman M (2016) . BMC Public Health, 16(1).
• Egan M, Brennan A, Buykx PF, De Vocht F, Gavens L, Grace D, Halliday E, Hickman M, Holt V, Mooney J & Lock K (2016) . Health and Place, 41, 11-18.
• Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J , Weaver T et al (2016) . Addiction, 111(9), 1616-1627.
• Ally A, Lovatt M, Meier PS, Brennan A & Holmes J (2016) . Addiction, 111(9), 1568-1579.
• De Vocht F, Heron J, Campbell R, Egan M, Mooney JD, Angus C, Brennan A & Hickman M (2016) . Journal of Epidemiology and Community Health, jech-2016-207753-jech-2016-207753.
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp M-M, Griffiths M, Agirrezabal I, Zuberbier T & Brennan A (2016) . PharmacoEconomics, 34(8), 815-827.
• Holmes J, Brown J, West R, Beard E, Brennan A, Drummond C, Gillespie D, Hickman M, Holmes J, Kaner E & Michie S (2016) . BMC Public Health, 16:535.
• Rafia R, Brennan A, Madan J, Collins K, Reed MWR, Lawrence G, Robinson T, Greenberg D & Wyld L (2016) . Value in Health, 19(4), 404-412.
• de Vocht F, Heron J, Angus C, Brennan A, Mooney J, Lock K, Campbell R & Hickman M (2016) . Journal of Epidemiology and Community Health, 70(3), 231-237.
• Meier PS, Holmes J, Angus C, Ally AK, Meng Y & Brennan A (2016) . PLOS Medicine, 13(2), e1001963-e1001963.
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y & Hill-Macmanus D (2016) . Annals of Operations Research, 236(1), 149-176.
• Brown J, West R, Angus C, Beard E, Brennan A, Drummond C, Hickman M, Holmes J, Kaner E & Michie S (2016) . British Journal of General Practice, 66(642), e1-e9.
• de Vocht F, Campbell R, Brennan A, Mooney J, Angus C & Hickman M (2016) . Public Health, 132, 40-49.
• (2016) . Diabetic Medicine, 33(8), 1155-1163.
• Price KJ, Knowles JA, Fox M, Wales JKH, Heller S, Eiser C, Freeman JV, Brennan A, Basirir H, Stevens K & McPherson A (2016) . Diabetic Medicine, 33(2), 192-203.
• Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, Smithson WH, Heller S, Gianfrancesco C, Gordon V , Greaves L et al (2016) . Diabetic Medicine, 33(2), 243-251.
• Cameron D, Norman P, Epton T, Sheeran P, Harris PR, Webb TL, Julious SA, Brennan A, Thomas C, Petroczi A , Naughton D et al (2015) . Trials, 16.
• Breeze P & Brennan A (2015) . Health Economics (United Kingdom), 24(11), 1468-1482.
• Kruger J, Pollard DJ, Basarir H, Thokala P, Cooke D, Clark M, Bond R, Heller S & Brennan A (2015) . Medical Decision Making, 35(7), 872-887.
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, Angus C & Holmes J (2015) . Health Economics, 24(10), 1368-1388.
• Strong M, Oakley JE, Brennan A & Breeze P (2015) . Medical Decision Making, 35(5), 570-583.
• Birch J, Scott S, Newbury-Birch D, Brennan A, Brown H, Coulton S, Gilvarry E, Hickman M, McColl E, McGovern R , Muirhead C et al (2015) . Pilot and Feasibility Studies, 1(1).
• Watson P, Brennan A, Birch H, Fang H & Petri M (2015) . Rheumatology, 54(4), 623-632.
• Ally AK, Meng Y, Chakraborty R, Dobson PW, Seaton JS, Holmes J, Angus C, Guo Y, Hill-McManus D, Brennan A & Meier PS (2014) . Addiction, 109(12), 1994-2002.
• Mooney JD, Holmes J, Brennan A, Meier PS, Hickman M & Lock K (2014) . The Lancet, 384, S52-S52.
• Holmes J, Meier PS, Booth A & Brennan A (2014) . Drug and Alcohol Review, 33(6), 596-603.
• Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S & Elliott J (2014) . Diabetes Research and Clinical Practice, 106(3), 443-450.
• Brennan A, Meng Y, Holmes J, Hill-McManus D & Meier PS (2014) . BMJ, 349.
• Holmes J, Guo Y, Maheswaran R, Nicholls J, Meier PS & Brennan A (2014) . Drug and Alcohol Review, 33(5), 515-525.
• Elliott J, Jacques RM, Kruger J, Campbell MJ, Amiel SA, Mansell P, Speight J, Brennan A & Heller SR (2014) . Diabet Med, 31(7), 847-853.
• Epton T, Norman P, Dadzie A-S, Harris PR, Webb TL, Sheeran P, Julious SA, Ciravegna F, Brennan A, Meier PS , Naughton D et al (2014) . Acta Veterinaria Scandinavica, 563-563.
• Watson P, Preston L, Squires H, Chilcott J & Brennan A (2014) . Appl Health Econ Health Policy, 12(3), 239-253.
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2014) . Lancet, 383(9929), 1655-1664.
• Strong M, Oakley JE & Brennan A (2014) . Medical Decision Making, 34(3), 311-326.
• Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014) . Diabet Med, 31(4), 477-486.
• Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J & Meier PS (2014) . J Health Econ, 34, 96-103.
• Angus C, Scafato E, Ghirini S, Torbica A, Ferre F, Struzzo P, Purshouse R & Brennan A (2014) . BMC Fam Pract, 15, 26.
• Meng Y, Holmes J, Hill-McManus D, Brennan A & Meier PS (2014) . Addiction, 109(2), 206-215.
• Kruger J, Brennan A, Strong M, Thomas C, Norman P & Epton T (2014) . BMC Public Health, 14(1).
• Purshouse RC, Ally AK, Brennan A, Moyo D & Norman P (2014) . Proceedings of the 2014 conference on Genetic and evolutionary computation - GECCO '14.
• Hill-McManus D, Angus C, Meng Y, Holmes J, Brennan A & Sylvia Meier P (2014) . Drug and Alcohol Dependence, 134(1), 136-143.
• Richards P & Brennan A (2013) . Trials, 14(S1).
• Strong M, Brennan A & Oakley J (2013) . Trials, 14(S1).
• Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013) . Health Technol Assess, 17(32), 1-vi.
• Norman P, Epton T, Dadzie A-S, Sheeran P, Harris P, Webb T, Ciravegna F, Julious S, Brennan A, Meier P , Kruger J et al (2013) A theory-based online intervention to promote health behaviour in new university students: One-month follow-up data. PSYCHOLOGY & HEALTH, 28, 132-132.
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S (2013) The cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) structured education in Type 1 diabetes: an update using the 91Ö±²¥ Type 1 diabetes policy model. DIABETIC MEDICINE, 30, 133-134.
• Meier PS, Meng Y, Holmes J, Baumberg B, Purshouse R, Hill-McManus D & Brennan A (2013) . Alcohol Alcohol, 48(2), 241-249.
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, Heller S & Speight J (2013) . DIABETIC MEDICINE, 30(10), 1236-1244.
• Purshouse RC, Brennan A, Rafia R, Latimer NR, Archer RJ, Angus CR, Preston LR & Meier PS (2013) . Alcohol Alcohol, 48(2), 180-188.
• Price KJ, Wales J, Eiser C, Knowles J, Heller S, Freeman J, Brennan A, McPherson A & Wellington J (2013) . BMJ Open, 3(1).
• Tosh J, Kearns B, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) Innovation in Health Economic Modelling of Service Improvements for Longer-Term Depression: Demonstration in a Local Health Community. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 16, S34-S35.
• Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J , Cowie MR et al (2013) . BMJ Open, 3(9), e003250.
• Tappenden P, Chilcott J, Brennan A, Squires H, Glynne-Jones R & Tappenden J (2013) . Value in Health.
• Tosh J, Kearns B, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) . BMC Health Serv Res, 13, 150.
• Epton T, Norman P, Sheeran P, Harris PR, Webb TL, Ciravegna F, Brennan A, Meier P, Julious SA, Naughton D , Petroczi A et al (2013) . BMC Public Health, 13, 107.
• Kruger J & Brennan A (2013) . Eur J Health Econ, 14(6), 887-899.
• Tappenden P, Chilcott J, Brennan A, Squires H & Stevenson M (2012) . Value Health, 15(8), 1127-1136.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) . Medical Decision Making, 32(5), 701-711.
• Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M, Black C, Boroujerdi M, Jick S, Wyness L , McNamee P et al (2012) . Health Technol Assess, 16(33), 1-iv.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) . Value in Health, 15(6), 821-827.
• Holmes J, Meier PS, Booth A, Guo Y & Brennan A (2012) . Drug and Alcohol Dependence, 123(1-3), 7-14.
• Tosh J, Brennan A, Wailoo A & Bansback N (2011) . Rheumatology (Oxford), 50 Suppl 4, iv26-iv31.
• Meier P & Brennan A (2011) . Journal of Epidemiology & Community Health, 65(Suppl 1), A47-A47.
• Kharroubi SA, Brennan A & Strong M (2011) . Med Decis Making, 31(6), 839-852.
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD & Akehurst R (2011) . Int J Geriatr Psychiatry, 26(5), 483-494.
• Gillett M, Dixon S, Dallosso HM, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) . BRIT MED J, 341.
• Karnon J, Brennan A & Akehurst R (2010) . MED DECIS MAKING, 30(3), E20-E22.
• Oakley JE, Brennan A, Tappenden P & Chilcott J (2010) . J Health Econ, 29(3), 468-477.
• Karnon J, Holmes MW, Williams R, Bakhai A & Brennan A (2010) . INT J CARDIOL, 140(3), 315-322.
• Purshouse RC, Meier PS, Brennan A, Taylor KB & Rafia R (2010) . Lancet, 375(9723), 1355-1364.
• Meier PS, Purshouse R & Brennan A (2010) . Addiction, 105(3), 400-401.
• Meier PS, Purshouse R & Brennan A (2010) . Addiction, 105(3), 383-393.
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) . BMJ, 341, c4093.
• Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV & Selby PL (2009) . Med Decis Making, 29(6), 678-689.
• Brennan A, Nagy B, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) . Aktuelle Neurologie, 36(S 02).
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) . Aktuelle Neurologie, 36(S 02).
• Nixon RM, O'Hagan A, Oakley J, Madan J, Stevens JW, Bansback N & Brennan A (2009) . PHARM STAT, 8(4), 371-389.
• Tappenden P, Chilcott J, Brennan A & Pilgrim H (2009) . Int J Technol Assess Health Care, 25(4), 470-478.
• Nixon RM, Bansback N, Stevens JW, Brennan A & Madan J (2009) . PHARM STAT, 8(2), 150-162.
• Nagy B, Brennan A, Brandtmuller A, Thomas S, Gallagher M, Sullivan SD & Akehurst R (2008) . Alzheimer's & Dementia, 4, T455-T455.
• Bansback N, Brennan A, Symmons D, Nixon R, Madan J, Harrison M & Watson K (2008) . RHEUMATOLOGY, 47(7), 1107-1107.
• Hadwin R, Eggington S, Brennan A, Walker P, Patnick J & Pilgrim H (2008) . BJOG-INT J OBSTET GY, 115(6), 749-757.
• Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM & Wolfe F (2008) . Arthritis Rheum, 58(4), 939-946.
• Wailoo AJ, Sutton AJ, Cooper NJ, Turner DA, Abrams KR, Brennan A & Nicholson KG (2008) . Value Health, 11(2), 160-171.
• Brennan A & Kharroubi SA (2007) . Health Econ, 16(11), 1205-1225.
• Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K & Symmons D (2007) . Rheumatology (Oxford), 46(8), 1345-1354.
• Nixon R, Bansback N & Brennan A (2007) . RHEUMATOLOGY, 46(7), 1140-1147.
• Brennan A, Kharroubi S, O'hagan A & Chilcott J (2007) . Med Decis Making, 27(4), 448-470.
• Karnon J, Brennan A & Akehurst R (2007) . Med Decis Making, 27(4), 491-499.
• Ara R & Brennan A (2007) . Obes Rev, 8(4), 363-371.
• Palmer AJ, Roze S, Valentine WJ, McEwan P, Gillett M, Holmes M, Clarke P, Stevens R, Gray AM, Coleman R , Sorensen S et al (2007) . DIABETES CARE, 30(6), 1638-1646.
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: literature review and economic modelling. HEALTH TECHNOL ASSES, 11(17), 1-+.
• Nixon RM, Bansback N & Brennan A (2007) . STAT MED, 26(6), 1237-1254.
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: Literature review and economic modelling. Health Technology Assessment, 11(17).
• Brennan A & Kharroubi SA (2007) . J Health Econ, 26(1), 122-148.
• Brennan A, Akehurst R, Davis S, Sakai H & Abbott V (2007) . Value Health, 10(1), 32-41.
• Brennan A, Ara R, Sterz R, Matiba B & Bergemann R (2006) . Eur J Health Econ, 7(4), 276-284.
• Brennan A, Chick SE & Davies R (2006) . Health Econ, 15(12), 1295-1310.
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. HEALTH TECHNOL ASSES, 10(30), 1-+.
• Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A & Emery P (2006) . Rheumatology (Oxford), 45(8), 1029-1038.
• Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D & Akehurst R (2006) . Int J Cardiol, 109(3), 307-316.
• Bansback N, Young A, Brennan A & Dixey J (2006) A prognostic model for functional outcome in early rheumatoid arthritis. Journal of Rheumatology, 33(8), 1503-1510.
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technology Assessment, 10(30).
• Brennan A, Sampson F & Deverill M (2005) . Health Serv Manage Res, 18(4), 265-276.
• Bansback N, Brennan A & Anis AH (2005) . Expert Rev Pharmacoecon Outcomes Res, 5(5), 519-529.
• Bansback NJ, Brennan A & Ghatnekar O (2005) . Ann Rheum Dis, 64(7), 995-1002.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) The Authors' Reply. PharmacoEconomics, 23(8), 853-853.
• Nuijten M, O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M , Spiegelhalter D et al (2005) . PharmacoEconomics, 23(8), 851-853.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) Incorporation of uncertainty in health economic modelling studies - The authors' reply. PHARMACOECONOMICS, 23(8), 853-853.
• Bansback NJ, Young A & Brennan A (2005) . RHEUMATOLOGY, 44(1), 3-4.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) . Pharmacoeconomics, 23(6), 529-536.
• Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) . Appl Health Econ Health Policy, 4(4), 201-208.
• Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH & Marra CA (2005) . Drugs, 65(4), 473-496.
• Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C & Akehurst R (2005) . Curr Med Res Opin, 21(1), 101-112.
• Brennan A & Bansback N (2004) . RHEUMATOLOGY, 43(5), 677-678.
• Bansback N, Brennan A, Sengupta N & Pang F (2004) THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA (TM)) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS. RHEUMATOLOGY, 43, 77-77.
• Bansback N, Brennan A, Young A, Sollymossy C, Dixey J & Dart H (2004) WHICH PATIENTS WITH EARLY RA DEVELOP FAST PROGRESSIVE DISEASE? PROGNOSTIC FACTORS FOR SEVERE FUNCTIONAL LOSS FROM AN INCEPTION COHORT WITH 9 YEAR FOLLOW UP. RHEUMATOLOGY, 43, 137-137.
• Brennan A, Bansback N, Reynolds A & Conway P (2004) . Rheumatology (Oxford), 43(1), 62-72.
• Warren E, Brennan A & Akehurst R (2004) . Med Decis Making, 24(1), 9-19.
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) . J Health Serv Res Policy, 8(1), 18-24.
• Karnon J, Brennan A & Chilcott J (2003) . Eur J Health Econ, 4(3), 239-240.
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) . Journal of Health Services Research & Policy, 8(1), 18-24.
• Chilcott J, Brennan A, Booth A, Karnon J & Tappenden P (2003) The role of modelling in prioritising and planning clinical trials.. Health technology assessment (Winchester, England), 7(23).
• Brennan A, Bansback N, Conway P & Reynolds A (2002) MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK. RHEUMATOLOGY, 41, 91-91.
• Stevenson M, Beard S, Finn A & Brennan A (2002) . Vaccine, 20(13-14), 1778-1786.
• Cornell SJ, Chilcott JB & Brennan A (2001) . J Epidemiol Community Health, 55(7), 521-527.
• Stevenson MD, Oakley PA, Beard SM, Brennan A & Cook AL (2001) . Injury, 32(4), 267-274.
• Brennan A & Akehurst R (2000) . Pharmacoeconomics, 17(5), 445-459.
• Opazo Breton M, Henney M, Kersbergen I, Brennan A & Holmes J () . Addiction.
• Davies MJ, Bodicoat DH, Brennan A, Dixon S, Eborall H, Glab A, Gray LJ, Hadjiconstantinou M, Huddlestone L, Hudson N , Keetharuth A et al () . BMC Primary Care, 25(1).
• Buckell J, Mitchell C, Fryer K, Newbert C, Brennan A, Joyce J, Aveyard P, Jebb S, Guess N & Morris E () Identifying preferred features of weight loss programmes for adults with, or at risk of, type 2 diabetes: a discrete choice experiment with 3,960 adults in the UK. Diabetes Care.
• Valiente R, Tunstall H, Kong AY, Wilson LB, Gillespie D, Angus C, Brennan A, Shortt NK & Pearce J () . Tobacco Control.
• Heathcote L, Pollard D, Brennan A, Davies M, Eborall H, Edwardson C, Gillett M, Gray L, Griffin S, Hardeman W , Henson J et al () A cost-effectiveness analysis of two interventions to promote physical activity in a multi-ethnic population at high risk of diabetes: an economic evaluation of the 48 month PROPELS Randomised Controlled Trial. BMJ Open Diabetes Research and Care.
• Hatchard J, Buykx P, Brennan A & Gillespie D () . NIHR Open Research, 3, 26-26.
• Hatchard J, Buykx P, Brennan A & Gillespie D () . NIHR Open Research, 3, 26-26.
• Søholm U, Zaremba N, Broadley M, Axelsen JL, Divilly P, Martine-Edith G, Amiel SA, Mader JK, Pedersen-Bjergaard U, McCrimmon RJ , Renard E et al () . JMIR Diabetes, 8, e42100-e42100.
• Hatchard J, Buykx P, Brennan A & Gillespie D () . NIHR Open Research, 3.
• Valiente R, Tunstall H, Kong A, Wilson L, Gillespie D, Angus C, Brennan A, Shortt N & Pearce J () . Tobacco Prevention & Cessation, 9(Supplement).
• Buckley C, Brennan A, Kerr W, Probst C, Puka K, Purshouse R & Rehm J () . International Journal of Alcohol and Drug Research.
• Breeze P, Gray LA, Thomas C, Bates SE & Brennan A () . Quality of Life Research.
• Wyld L, Reed MWR, Collins K, Ward S, Holmes G, Morgan J, Bradburn M, Walters S, Burton M, Lifford K , Edwards A et al () . Programme Grants for Applied Research, 10(6), 1-114.
• Tew M, Willis M, Asseburg C, Bennett H, Brennan A, Feenstra T, Gahn J, Gray A, Heathcote L, Herman WH , Isaman D et al () . Medical Decision Making, 0272989X2110654-0272989X2110654.
• Meier PS, Holmes J, Brennan A & Angus C () . Addiction.
• Wilson LB, Pryce R, Hiscock R, Angus C, Brennan A & Gillespie D () . Tobacco Control.
• Holmes J, Beard E, Brown J, Brennan A, Meier PS, Michie S, Stevely AK, Webster L & Buykx PF () . Journal of Epidemiology and Community Health.
• Schneider PP, Smith RA, Bullas AM, Bayley T, Haake SSJ, Brennan A & Goyder E () .
• Moyo D, Ally AK, Brennan A, Norman P, Purshouse RC & Strong M () . Journal of Artificial Societies and Social Simulation, 18(3).
• Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, Elliott J, Boote J, Emery C, Baird W , Basarir H et al () . Programme Grants for Applied Research, 2(5), 1-188.
• Brennan A, Buckley C, Vu TM, Probst C, Nielsen A, Bai H, Broomhead T, Greenfield T, Kerr W, Meier PS , Rehm J et al () . International Journal of Microsimulation, 13(2), 21-60.
• Bates S, Norman P, Breeze P, Brennan A & Ahern A () Mechanisms of action in a behavioural weight-management programme: Latent growth curve analysis. Annals of Behavioral Medicine.
• Thomas C, Brennan A, Squires H, Brenner G, Bagguley D, Woods H, Gillett M, Leaviss J, Clowes M, Heathcote L , Cooper K et al () What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open.
• Horton M, Perman-Howe PR, Angus C, Bishop J, Bogdanovica I, Brennan A, Britton J, Brose LS, Brown J, Collin J , Dockrell M et al () . Wellcome Open Research, 6, 6-6.
• Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S & Gray LJ () . Health Technology Assessment, 19(33), 1-80.
• Wilson LB, Angus C, Pryce R, Holmes J, Brennan A & Gillespie D () . Addiction.
• Breeze P, Thomas C, Thokala P, LaFortune L, Brayne C & Brennan A () The impact of including costs and outcomes of dementia in a health economic model to evaluate lifestyle interventions to prevent diabetes and cardiovascular disease. Medical Decision Making.
• Moore S, Young T, Irving A, Goodacre S, Brennan A & Amos Y () . Emergency Medicine Journal.
• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A () Conceptualising changes to tobacco and alcohol policy as affecting a single interlinked system. BMC Public Health.
• Coates E, Amiel S, Baird W, Benaissa M, Brennan A, Campbell M, Chadwick P, Chater T, Choudhary P, Cooke D , Cooper C et al () . BMJ Open.
• Wilson LB, Pryce R, Angus C, Hiscock R, Brennan A & Gillespie D () . The European Journal of Health Economics.
• Purshouse RC, Buckley C, Brennan A & Holmes J () . Addiction.
• Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J () . Addiction.

Chapters

• Grimm S, Brennan A & Heath A (2024) , Value of Information for Healthcare Decision-Making (pp. 251-263).
• Grimm S, Brennan A & Heath A (2023) , Value of Information for Healthcare Decision-Making (pp. 251-264). Chapman and Hall/CRC
• Payne N, Akehurst R, Beard S, Brennan A, Calvert N, Chilcott J, Mccabe C, Paisley S & Ward S (2017) Supporting purchasing in acute specialties in the trent region, Controlling Costs: Strategic Issues in Health Care Management (pp. 118-130).
• Heath A, Kunst N & Jackson C () Chapman and Hall/CRC

Conference proceedings papers

• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Ganguli P, Byford S, Hayes R & Brennan A (2024) . SSM Annual Scientific Meeting (pp A63.1-A63)
• Hoehn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Comrie E, Elsenbroich C, Hughes C & Katikireddi SV (2023) . SSM Annual Scientific Meeting
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) PUBLIC HEALTH ECONOMIC MODELLING IN EVALUATIONS OF SALT AND ALCOHOL POLICIES: A SCOPING REVIEW. VALUE IN HEALTH, Vol. 26(12) (pp S544-S544)
• Mueller J, Breeze P, Griffin S, Brennan A, Hill A, Morris S, Hughes CA, Woolston J, Lachassseigne E, Stubbings M , Sharp S et al (2023) Diabetes Education and Behavioral Weight Management for Type 2 Diabetes: A Randomized Controlled Trial. OBESITY, Vol. 31 (pp 47-48)
• Bryning S, Jones GF, Pollit V & Brennan A (2022) WHEN IS A SIMPLE MODEL GOOD ENOUGH? TOWARDS GREATER USE OF FORMAL METHODS FOR EVALUATING STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S350-S351)
• Holding E, Foster A, Lumley E, Brennan A, Gillett M & Goyder E (2021) . The Lancet, Vol. 398(Supplement 2) (pp S53-S53). Virtual conference, 25 November 2021 - 25 November 2021.
• Bates S, Breeze P, Norman P & Brennan A (2021) . The Lancet, Vol. 398(Supplement 2) (pp 23-23). Virtual conference, 26 November 2021 - 26 November 2021.
• Breeze P, Sworn K, Abraham S, McGrane E, Cantrell A & Brennan A (2021) . The Lancet, Vol. 398 (pp S27-S27)
• Clarke AE, St-Pierre Y, Paly V, Bruce IN, Malmberg C, Briggs A, Zhang Y, Choi J & Brennan A (2021) . Annals of the Rheumatic Diseases, Vol. 80(Suppl 1) (pp 617.2-618)
• (2020) . Medical Decision Making, Vol. 40(1) (pp E1-E379)
• Kunst NR, Wilson ECF, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) PRACTICAL CONSIDERATIONS FOR THE EFFICIENT COMPUTATION OF THE EXPECTED VALUE OF SAMPLE INFORMATION TO PRIORITIZE RESEARCH IN HEALTH CARE. MEDICAL DECISION MAKING, Vol. 40(1) (pp E63-E64)
• Flight L, Julious S, Brennan A & Todd S (2020) METHODS FOR CHOOSING THE BEST DESIGN OF A CLINICAL TRIAL: IMPLEMENTING EXPECTED VALUE OF SAMPLE INFORMATION AND ADJUSTING FOR BIAS INDUCED BY A GROUP SEQUENTIAL DESIGN. MEDICAL DECISION MAKING, Vol. 40(1) (pp E188-E189)
• Holmes J, Beard E, Brennan A, Brown J, Gillespie D, Meier PS, Michie S, Stevely AK, Webster L & Buykx P (2019) . The Lancet, Vol. 394 (pp S54-S54). London, UK, 29 November 2019 - 29 November 2019.
• Pollard D, Brennan A, Coates L & Heller S (2019) . Value in Health, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) . Value in Health, Vol. 22 (pp S577-S577)
• Schneider PP, Smith R, Bullas A, Haake S, Brennan A & Goyder E (2019) . European Journal of Public Health, Vol. 29(Supplement_4)
• Hatchard J, Buykx P, Brennan A & Gillespie D (2019) . The Lancet, Vol. 394 (pp S51-S51)
• de Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, Cummins S, De Angelis D , Carter N et al (2019) . The Lancet, Vol. 394 (pp S35-S35)
• O'Cathain A, Croot E, Duncan E, Rousseau N, Sworn K, Turner K, Yardley L & Hoddinott P (2019) . Trials, Vol. 20(Supplement 1) (pp 99-99). Brighton, UK, 6 October 2019 - 9 October 2019.
• Flight L, Hind D, Julious S, Brennan A & Todd S (2019) . Trials, Vol. 20(Supplement 1) (pp 109-109). Brighton, UK, 6 October 2019 - 9 October 2019.
• Vu TM, Probst C, Epstein JM, Brennan A, Strong M & Purshouse RC (2019) . Proceedings of the Genetic and Evolutionary Computation Conference
• Purshouse RC, Vu T, Bai H, Buckley CM, Nielsen AE, Probst C & Brennan A (2019) ALCOHOL POLICY MODELING USING THEORY - A NEW COMPUTATIONAL PLATFORM FOR DEVELOPING MECHANISM-BASED EXPLANATORY MODELS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 142A-142A)
• Nielsen AE, Brennan A, Kerr W & Purshouse R (2019) SYNTHESIZING THE RATIONAL ADDICTION AND MYOPIC CHOICE ECONOMIC MODELS TO EXPLAIN POPULATION ALCOHOL USE AND UNDERSTAND PRICING POLICIES: AN AGENT-BASED SIMULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 141A-141A)
• Paly V, Brennan A, Mukherjee J, Alemao E, Napoli A, Sidhu M, Perdrizet J, Clarke AE, Bruce I & Briggs A (2019) . Value in Health, Vol. 22 (pp S374-S374)
• Pollard D, Brennan A, Coates L & Heller S (2019) PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. VALUE IN HEALTH, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. VALUE IN HEALTH, Vol. 22 (pp S577-S577)
• Purshouse RC, Nielsen A & Brennan A (2018) A CONCEPTUAL FRAMEWORK FOR MODELING ALCOHOL USE DYNAMICS OVER OPULATION HEALTH TIME HORIZONS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Broomhead T, Purshouse R, Strong M, Brennan A, Kerr W, Greenfield T, Nielsen A & Probst C (2018) PLATFORM FOR CALIBRATED, SYSTEM-BASED MODELS OF ALCOHOL USE DYNAMICS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Porter JK, Di Tanna GL, Lipton RB, Brennan A, Palmer S, Sapra S & Villa G (2018) . Value in Health, Vol. 21 (pp S206-S206)
• Brennan A, Pollard D, Coates L, Strong M & Heller S (2017) . Value in Health, Vol. 20(9) (pp A776-A776)
• Lipton RB, Porter JK, Shah N, Sapra S, Desai P, Villa G, Brennan A, Palmer S & Jansen J (2017) A comparison of approaches to model migraine day frequency in migraine. CEPHALALGIA, Vol. 37 (pp 102-103)
• Porter JK, Brennan A, Palmer S, Sapra S, Shah N, Desai P, Villa G & Lipton AB (2017) MODELING MIGRAINE DAY FREQUENCY USING THE BETA-BINOMIAL DISTRIBUTION: A CASE STUDY OF ERENUMAB AS MIGRAINE PROPHYLAXIS. VALUE IN HEALTH, Vol. 20(5) (pp A329-A329)
• Porter JK, DiTanna GL, Villa G, Brennan A, Palmer S, Lipton RB, Jansen JP, Shah N, Desai P & Sapra S (2017) PARAMETRIC MODELLING OF MIGRAINE DAY FREQUENCY IN MIGRAINE PREVENTION: A CASE STUDY OF ERENUMAB CLINICAL TRIAL DATA. VALUE IN HEALTH, Vol. 20(9) (pp A733-A733)
• Lipton RB, Brennan A, Palmer S, Jansen JP, Hatswell AJ, Porter JK, Di Tanna GL, Villa G, Shah N & Sapra S (2017) NOVEL BIOLOGICS VERSUS CONVENTIONAL PREVENTIVE THERAPIES IN MIGRAINE: A FRAMEWORK FOR ECONOMIC EVALUATION. VALUE IN HEALTH, Vol. 20(9) (pp A732-A732)
• Upsher RJ, Stahl D, Pollard D, Gillett M, Brennan A, Heller S, Ismail K & Winkley K (2017) A Systematic Review of Psychological Interventions to Improve Glycaemic Control in Type 1 Diabetes. DIABETES, Vol. 66 (pp A214-A214)
• Mooney JD, Holmes J, Gavens L, de Vocht F, Hickman M, Lock K & Brennan A (2017) . BMC Public Health, Vol. 17(1)
• Thokala P, Brennan A, Lafortune L & Brayne C (2016) . Value in Health, Vol. 19(7) (pp A853-A853)
• Porter JK, Brennan A, Palmer S, Sapra S & Cristino J (2016) . Value in Health, Vol. 19(7) (pp A361-A361)
• de Vocht F, Heron J, Mooney J, Angus C, Lock K, Egan M, Campbell R, Brennan A & Hickman M (2016) . Journal of Epidemiology and Community Health, Vol. 70(Suppl 1) (pp A83.1-A83)
• de Vocht F, Heron J, Mooney J, Brennan A, Lock K, Campbell R & Hickman M (2015) . The Lancet, Vol. 386 (pp S33-S33)
• Strong M, Brennan A & Oakley J (2015) . Value in Health, Vol. 18(7) (pp A725-A726)
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp M, Griffiths M, Agirrezabal I & Brennan A (2015) . Value in Health, Vol. 18(7) (pp A423-A423)
• Meier PS, Holmes J, Meng Y & Brennan A (2014) . The Lancet, Vol. 384 (pp S51-S51)
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2013) Minimum unit pricing for alcohol: policy appraisal modelling of income and socioeconomic group-specific effects on consumption, spending, and health harms. LANCET, Vol. 382 (pp 47-47)
• Thokala P, Baalbaki H & Brennan A (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A530-A530)
• Thokala P, Brennan A & Baalbaki H (2013) . Value Health, Vol. 16(3) (pp A290). United States
• Watson P & Brennan A (2013) . Value Health, Vol. 16(3) (pp A29). United States
• Sutherland CS, Gillet M, Brennan A, Duran A & Ansolabehere X (2013) . VALUE IN HEALTH, Vol. 16(3) (pp A284-A284)
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R & Elliott J (2013) The cost-effectiveness of five week vs one week DAFNE structured education in Type 1 diabetes: a preliminary evaluation using the 91Ö±²¥ Type 1 diabetes policy model. DIABETIC MEDICINE, Vol. 30 (pp 131-131)
• Brennan A, Thokala P, Baalbaki H, Stevens JW, Wang J & Pandor A (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A360-A360)
• Thokala P, Kruger J & Brennan A (2012) . VALUE IN HEALTH, Vol. 15(4) (pp A181-A182)
• Watson P & Brennan A (2012) Validation of an individual patient level simulation of the natural history of systemic Lupus erythematosus against an alternative longitudinal cohort. 2012 Operational Research Society Simulation Workshop, SW 2012 (pp 19-24)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A469-A470)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A243-A243)
• Watson P, Brennan A, Birch H, Fang H & Petri M (2011) The Natural History and Predictive Factors of Long Term Outcomes in Systemic Lupus Erythematosus.. ARTHRITIS AND RHEUMATISM, Vol. 63(10) (pp S951-S951)
• Meier P, Brennan A & Purshouse R (2010) MODELLING GENERAL AND TARGETED PRICE POLICY OPTIONS: ESTIMATION OF EFFECTS ON DIFFERENT SUBGROUPS OF THE POPULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(6) (pp 251A-251A)
• Brennan A & Gillett M (2010) MODELLING COST EFFECTIVENESS OF BEHAVIOUR MODIFICATION PROGRAMMES AND EFFECTS ON MEDICATION: CASE STUDY OF EDUCATION PROGRAMMES IN DIABETES. VALUE HEALTH, Vol. 13(3) (pp A59-A59)
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K & Davies MJ (2009) Cost effectiveness of the DESMOND structured education programme for patients newly diagnosed with type 2 diabetes. DIABETOLOGIA, Vol. 52 (pp S12-S12)
• Brennan A, Gillett M & Duenas A (2008) ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL. VALUE HEALTH, Vol. 11(6) (pp A501-A501)
• Stevenson MD, Rawdin AC, Karnon JD & Brennan A (2008) Clopidogrel is cost-effective compared with aspirin in United Kingdom patients with a myocardial infarction who subsequently sustain an ischaemic stroke or peripheral arterial disease event. VALUE HEALTH, Vol. 11(3) (pp A194-A195)
• Brennan A, Nagy B, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2007) The cost-utility of exelon patch in the management of patients with moderate Alzheimer's disease in the United Kingdom. VALUE HEALTH, Vol. 10(6) (pp A384-A384)
• Brennan A, Wilson R, Davis S, Brandtmuller A & Akehurst R (2007) Economic evaluation of the use of lanthanum carbonate from an Australian perspective. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 22 (pp 186-186)
• Nixon R, Bansback N & Brennan A (2007) Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. VALUE HEALTH, Vol. 10(3) (pp A121-A121)
• Ara RM, Reynolds AV, Conway P & Brennan A (2006) The cost effectiveness of etanercept in patients with severe as in the UK. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-274)
• Brennan A, Bansback NJ, Nixon R, Madan J & Symmons D (2006) The cost effectiveness of anti-TNF antagonists in rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Registry. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 179-179)
• Bansback N, Young A, Dixey J & Brennan A (2005) A simple prognostic index in early rheumatoid arthritis for predicting functional outcome at 5 years follow up. RHEUMATOLOGY, Vol. 44 (pp I97-I97)
• Brennan A, Akehurst R, Davis S & Sakai H (2004) Lanthanum carbonate for the treatment of hyperphosphataemia: Development of a cost effectiveness model. VALUE HEALTH, Vol. 7(6) (pp 805-805)
• Bansback NJ, Brennan A & Sengupta N (2004) The cost effectiveness of adalimumab (HUMIRA (R)) in patients with RA: A Finnish analysis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 513-514)
• Bansback NJ, Young A, Sollymossy C, Dixey J & Brennan A (2004) A prognostic model for progressive disease in early rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 110-110)
• Bansback NJ, Brennan A, Sengupta N & Pang F (2004) The cost effectiveness of adalimumab (HUMIRA((R))) in UK patients with moderate to severe RA. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 512-513)
• Brennan A & Ara R (2004) Cost effectivness of obesity treatment with sibutramine in combination with diet and lifestyle advice in Germany. INTERNATIONAL JOURNAL OF OBESITY, Vol. 28 (pp S152-S152)
• Bansback N, Brennan A & Sengupta N (2004) Cost-effectiveness of adalimumab (Humira (TM)) in the treatment of US patients with rheumatoid arthritis (RA). VALUE HEALTH, Vol. 7(3) (pp 241-241)
• Bansback NJ, Brennan A, Sengupta N & Chang KY (2003) Cost effectiveness of adalimumab (HUMIRA (TM), Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S215-S215)
• Bansback NJ, Brennan A, Ghatnekar O, Sengupta N, Chang KY & Hansen M (2003) The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S611-S611)
• Bansback N, Brennan A, Young A, Solymossy C & Dixey J (2003) Identifing groups of RA patients who are fast Progressors from early clinical and radiological. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S110-S110)
• Brennan A, Ward S & Hummel S (2002) Costing the impact of the cancer service guidance. Journal of Clinical Excellence, Vol. 4(1 SUPPL.) (pp 209-210)
• Bansback N, Brennan A, Conway P & Reynolds AV (2002) A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S582-S582)
• Brennan A, Bansback N, Martha K, Peacock M & Huttner K (2002) Methods to analyse the economic benefits of a pharmacogenetic (PGt) test to predict response to biologic therapy in RA, and to prioritise further research.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S92-S92)
• Brennan A, Bansback N, Conway P & Reynolds AV (2001) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S157-S157)
• Bansback N, Brennan A, Reynolds A, Conway P & Hammond T (2001) In rheumatoid arthritis (RA) utility calculations should be derived from EQ5D rather than SF-36 due to floor effects.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S311-S311)
• (2000) . PharmacoEconomics, Vol. 17(5) (pp 443-444)
• Tian D, Squires H, Buckley C, Gillespie D, Tattan-Birch H, Shahab L, West R, Brennan A, Brown J & Purshouse R () Incorporating the COM-B model for behavior change into an agent-based model of smoking behaviors: an object-oriented design. Proceedings of the 2024 Winter Simulation Conference. Orlando, Florida, 15 December 2024 - 15 December 2024.
• Basirir H, Brennan A, Jacques R, Pollard D, Stevens K, Freeman J, Wales J & Price K () . Endocrine Abstracts
• Thokala P, Baalbaki H, Lowrie K, Dixon S & Brennan A () . International Journal of Integrated Care, Vol. 13(7)
• Kruger J, Brennan A, Thokala P, Cooke D & Heller S () Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions: A Case Study in Type 1 Diabetes. ISPOR 17th Annual International Meeting. Washington DC, June 2012.
• Kruger J, Brennan A, Thokala P, Fitzgerald P & Heller S ()
• Vu TM, Davies E, Buckley C, Brennan A & Purshouse R () Using Multi-objective Grammar-based Genetic Programming to Integrate Multiple Social Theories in Agent-based Modeling. Lecture notes in computer science

Reports

• Forster M, Flight L, Corbacho B, Keding A, Ronaldson S, Tharmanathan P, Welch C, Brennan A & Chick S (2021) Report for the EcoNomics of Adaptive Clinical Trials (ENACT) project: Application of a Bayesian Value-Based Sequential Model of a Clinical Trial to the CACTUS and HERO Case Studies (with Guidance Material for Clinical Trials Units)
• Hill J, Breeze P, Chrysanthou G, Bell H & Brennan A (2019) Summary report of the Health and Labour Outcomes (HaLO) Tool
• Webster L, Angus C, Brennan A & Gillespie D (2018)
• Hill J, Sechel C, Mukuria C, Brennan A, Roberts J & Bryan M (2018) A feasibility study for building a health and work model. Report prepared for Public Health England
• Pryce RE, Buykx P, Gray L, Stone T, Drummond C & Brennan A (2017) Estimates of alcohol dependence in England based on APMS 2014, including estimates of children living in a household with an adult with alcohol dependence. Prevalence, trends, and amenability to treatment
• Brennan A, Buykx P, Pryce RE, Jones A, Hill-McManus D, Stone T, Ally A, Gillespie D, Meier P, Alston R , Cairns D et al (2016) An Evidence-Based Model for Estimating Requirements for Specialist Alcohol Treatment Capacity in England The Specialist Treatment for Alcohol Model (STreAM) Version 1.0
• Pryce RE, Angus C, Holmes J, Meier P & Brennan A (2016) Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Scotland. An adaptation of the 91Ö±²¥ Alcohol Policy Model version 3,
• Holmes J, Angus C, Buykx P, Ally A, Stone A, Meier P & Brennan A (2016) Mortality and morbidity risks from alcohol consumption in the UK: Analyses using the 91Ö±²¥ Alcohol Policy Model (v.2.7) to inform the UK Chief Medical Officers’ review of the UK lower risk drinking guidelines
• Holmes J, Lovatt MJ, Ally A, Brennan A & Meier P (2015) A new approach to measuring drinking cultures in Britain
• Koh SCL, Marchand R, Genovese A & Brennan A (2012) Fuel Poverty: Perspectives from the front line
• Webster L, Angus C, Holmes J, Brennan A & Gillespie D ()
• Webster L, Angus C, Brennan A & Gillespie D ()

Posters

• Nagy B, Brennan A, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2008) Cost-Utility of the Rivastigmine Transdermal Patch in the Management of Patients with Moderate Alzheimer's Disease in the US.
• Sadler S, Angus C, Gell L, Gillespie D, Holmes J, Brennan A & Meier P Comparing socioeconomic gradients in alcohol-related harm between the four UK countries (PHE Applied Epidemiology Scientific Meeting 18-19 March 2015).
• Thokala P, Dodd P, Dixon S & Brennan A Using real world data to structure and populate Markov models - a case study of telemonitoring for heart failure.
• Brennan A, Thokala P, Baalbaki H, Stevens J, Wang J & Pandor A Telemonitoring after discharge with heart failure - costeffectiveness modelling of alternative service designs (2012).
• Basarir H, Kruger J, Brennan A, Thokala P, Jacques R, Dixon S, Elliott J, Heller S & Mansell P The Cost-Effectiveness of 5-week versus 1-week DAFNE Structured Education in Type 1 Diabetes: A Preliminary Evaluation Using the 91Ö±²¥ Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S The Cost-Effectiveness of Dose Adjustment For Normal Eating (DAFNE) Structured Education in Type 1 Diabetes: An Update using the 91Ö±²¥ Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Tosh J, Brennan A & Parry G Health economic modelling of the service of care in 91Ö±²¥ for patients with long term depression.
• Brennan A & Gillett M Modelling cost effectiveness of behaviour modification programmes and effects on medication: case study of education programmes in diabetes.
• Tappenden P, Brennan A, Chilcott J & Squires H Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and followup of colorectal cancer.

Datasets

• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A .

Other

• Gillespie D, Webster L & Brennan A () .
• Gillespie D, Webster L, Angus C & Brennan A () .

Preprints

• Kunst NR, Wilson E, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2019) Computing the Expected Value of Sample Information Efficiently: Expertise and Skills Required for Four Model-Based Methods, arXiv.
• Angus C, Holmes J, Purshouse R, Meier P & Brennan A () , Cold Spring Harbor Laboratory.
• Flight L, Brennan A, Chick SE, Forster M, Julious S & Tharmanathan P () Value-Adaptive Clinical Trial Designs for Efficient Delivery of Research – Actions, Opportunities and Challenges for Publicly Funded Trials.
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () .
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () .
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al () , JMIR Publications Inc..